Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa

References

• Latent tuberculosis infection: updated and consolidated guidelines for programmatic management [Internet]. World Health Organization; 2018 [cited 2021 Jul 25]. Available from: https://apps.who.int/iris/handle/10665/260233
   Google Scholar
• Guidelines for tuberculosis preventive therapy among HIV-infected individuals in South Africa [Internet]. South Africa Department of Health; 2010 [cited 2021 Jul 25]. Available from: https://www.who.int/hiv/pub/guidelines/south_africa_hiv_tb.pdf
   Google Scholar
• Global tuberculosis report 2020 [Internet]. World Health Organization; 2020 [cited 2021 Jul 25]. Available from: https://www.who.int/tb/publications/global_report/en/
   Google Scholar
• UNAIDS data 2019 [Internet]. UNAIDS; 2019 [cited 2021 Jul 25]. Available from: https://www.unaids.org/en/resources/documents/2019/2019-UNAIDS-data
   Google Scholar
• Chehab JC, Vilakazi-Nhlapo K, Vranken P, et al. Survey of isoniazid preventive therapy in South Africa, 2011. Int J Tuberc Lung Dis. 2012;16:903–9. PubMed PMID: 22583688.
   PubMed Web of Science ®Google Scholar
• Codecasa LR, Murgia N, Ferrarese M, et al. Isoniazid preventive treatment: predictors of adverse events and treatment completion. Int J Tuberc Lung Dis. 2013;17:903–908. PubMed PMID: 23651743.
   PubMed Web of Science ®Google Scholar
• Global tuberculosis report 2019 [Internet]. World Health Organization; 2019 [cited 2021 Jul 25]. Available from: https://www.who.int/tb/publications/global_report/en/
   Google Scholar
• Jacobson KB, Niccolai L, Mtungwa N, et al. “It’s about my life”: facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa. AIDS Care. 2017;29:936–942. PubMed PMID: 28147705; PubMed Central PMCID: PMC5545149.
   PubMed Web of Science ®Google Scholar
• Boffa J, Mayan M, Ndlovu S, et al. When prevention is dangerous: perceptions of isoniazid preventive therapy in KwaZulu-Natal, South Africa. Public Health Action. 2019;9:24–31. PubMed PMID: 30963039; PubMed Central PMCID: PMC6436494.
   Web of Science ®Google Scholar
• Lester R, Hamilton R, Charalambous S, et al. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS. 2010;24:S45–8. PubMed PMID: 21079427.
   PubMed Web of Science ®Google Scholar
• Jarrett BA, Woznica DM, Tilchin C, et al. Promoting tuberculosis preventive therapy for people living with HIV in South Africa: interventions Hindered by complicated clinical guidelines and imbalanced patient-provider dynamics. AIDS Behav. 2020;24:1106–1117. PubMed PMID: 31549265; PubMed Central PMCID: PMC7085432.
   Web of Science ®Google Scholar
• Lai J, Dememew Z, Jerene D, et al. Provider barriers to the uptake of isoniazid preventive therapy among people living with HIV in Ethiopia. Int J Tuberc Lung Dis. 2019;23:371–377. PubMed PMID: 30871669; PubMed Central PMCID: PMC6822021.
   Web of Science ®Google Scholar
• Damschroder LJ, Aron DC, Keith RE, et al. Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science. Implement Sci. 2009;4:50. PubMed PMID: 19664226; PubMed Central PMCID: PMC2736161.
   PubMed Web of Science ®Google Scholar
• Mid-year population estimates 2015 [Internet]. Department of Statistics South Africa; 2016 [cited 2021 Jul 25]. Available from: https://www.statssa.gov.za/publications/P0302/P03022015.pdf
   Google Scholar
• Shenoi SV, Moll AP, Brooks RP, et al. Integrated tuberculosis/human immunodeficiency virus community-based case finding in rural South Africa: implications for tuberculosis control efforts. Open Forum Infect Dis. 2017;4:ofx092. PubMed PMID: 28695145; PubMed Central PMCID: PMC5499582.
   Web of Science ®Google Scholar
• Massyn N, Pillay Y, Padarath A. District health barometer 2017/18 [Internet]. Health Systems Trust; 2019 [cited 2021 Jul 25]. Available from: https://www.hst.org.za/publications/District%20Health%20Barometers/DHB+2017-18+Web+8+Apr+2019.pdf
   Google Scholar
• Adams LV, Maseko TSB, Talbot EA, et al. Integrated and patient-selected care facilitates completion of isoniazid preventive therapy in Eswatini. Public Health Action. 2019;9:153–158. PubMed PMID: 32042607; PubMed Central PMCID: PMC6945734.
   Web of Science ®Google Scholar
• Bulali RE, Kibusi SM, Mpondo BCT. Factors associated with HIV status disclosure and its effect on treatment adherence and quality of life among children 6-17 years on antiretroviral therapy in Southern Highlands Zone, Tanzania: unmatched case control study. Int J Pediatr. 2018;2018:8058291. PubMed PMID: 30046314; PubMed Central PMCID: PMC6038591.
   Web of Science ®Google Scholar
• Grande SW, Adams LV, Maseko TSB, et al. The social implications of participant choice on adherence to isonaizid preventive therapy (IPT): a follow-up study to high completion rates in Eswatini. PLoS One. 2020;15:e0232841. PubMed PMID: 32469990; PubMed Central PMCID: PMC7259658.
   Web of Science ®Google Scholar
• Rowe KA, Makhubele B, Hargreaves JR, et al. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Int J Tuberc Lung Dis. 2005;9:263–269. PubMed PMID: 15786888.
   PubMed Web of Science ®Google Scholar
• Rangaka MX, Wilkinson RJ, Boulle A, et al. Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial. Lancet. 2014 Aug 23;384:682–690. PMID: 24835842; PMCID: PMC4233253.
   PubMed Web of Science ®Google Scholar
• Teklay G, Teklu T, Legesse B, et al. Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study. BMC Public Health. 2016;16:840. PubMed PMID: 27543096; PubMed Central PMCID: PMC4992328.
   PubMed Web of Science ®Google Scholar
• Yunusa F, Bello M, Kayode GA, et al. Uptake of tuberculosis prevention therapy in people living with HIV/AIDS in northern Nigeria: a programme to increase use of isoniazid preventive therapy. Lancet Glob Health. 2020;8:S37.
   Web of Science ®Google Scholar
• Reddy MM, Thekkur P, Ramya N, et al. To start or to complete? - Challenges in implementing tuberculosis preventive therapy among people living with HIV: a mixed-methods study from Karnataka, India. Glob Health Action. 2020;13:1704540. PubMed PMID: 31937200; PubMed Central PMCID: PMC7006687.
   PubMed Web of Science ®Google Scholar
• Van Ginderdeuren E, Bassett J, Hanrahan C, et al. Health system barriers to implementation of TB preventive strategies in South African primary care facilities. PLoS One. 2019;14:e0212035. PubMed PMID: 30763378; PubMed Central PMCID: PMC6375590.
   PubMed Web of Science ®Google Scholar
• Mindachew M, Deribew A, Memiah P, et al. Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study. Pan Afr Med J. 2014;17. PubMed PMID: 24932337; PubMed Central PMCID: PMC4048699. DOI:https://doi.org/10.11604/pamj.2014.17.26.2641
   Google Scholar
• Abdulrazaak A, Govender I, Nzaumvila D. Knowledge, attitudes and practices of doctors regarding isoniazid preventive therapy in HIV/AIDS patients at Odi District Hospital, Gauteng province, South Africa. S Afr J Infect Dis. 2018;1–11. DOI:https://doi.org/10.1080/23120053.2018.1548726
   Google Scholar